Track RCKT and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
RCKT - Rocket Pharmaceuticals Inc (RCKT) has a free cash flow of -$179.79M, up 11.7% over the past year and down 25.8% per year over the past five years.
FCF TTM
-$179.79M
FCF Margin
-
FCF Yield
-48.54%
5Y CAGR
-25.82%
| Year | Free Cash Flow | Change |
|---|---|---|
| 2025 | -$190.47M | +11.68% |
| 2024 | -$215.66M | -1.99% |
| 2023 | -$211.46M | -13.17% |
| 2022 | -$186.84M | -43.15% |
| 2021 | -$130.52M | -25.87% |
| 2020 | -$103.70M | -17.93% |
| 2019 | -$87.93M | -59.18% |
| 2018 | -$55.24M | -110.98% |
| 2017 | -$26.18M | - |
| Quarter | Free Cash Flow | Change |
|---|---|---|
| Q1 2026 | -$45.49M | -30.26% |
| Q4 2025 | -$34.92M | +30.68% |
| Q3 2025 | -$50.37M | -2.77% |
| Q2 2025 | -$49.01M | +12.73% |
| Q1 2025 | -$56.17M | -18.83% |
| Q4 2024 | -$47.27M | +11.97% |
| Q3 2024 | -$53.69M | +3.75% |
| Q2 2024 | -$55.78M | +5.32% |
| Q1 2024 | -$58.92M | -73.21% |
| Q4 2023 | -$34.02M | +44.96% |
| Q3 2023 | -$61.80M | -12.33% |
| Q2 2023 | -$55.02M | +9.24% |
| Q1 2023 | -$60.62M | -2.18% |
| Q4 2022 | -$59.32M | -33.72% |
| Q3 2022 | -$44.36M | -5.79% |
| Q2 2022 | -$41.94M | -1.73% |
| Q1 2022 | -$41.22M | -24.98% |
| Q4 2021 | -$32.98M | -4.01% |
| Q3 2021 | -$31.71M | +23.18% |
| Q2 2021 | -$41.28M | -68.16% |
| Q1 2021 | -$24.55M | +12.42% |
| Q4 2020 | -$28.03M | -32.35% |
| Q3 2020 | -$21.18M | +19.85% |
| Q2 2020 | -$26.42M | +5.87% |
| Q1 2020 | -$28.07M | +3.16% |
| Q4 2019 | -$28.99M | -65.08% |
| Q3 2019 | -$17.56M | +28.76% |
| Q2 2019 | -$24.65M | -47.27% |
| Q1 2019 | -$16.74M | +22.86% |
| Q4 2018 | -$21.70M | -79.49% |
| Q3 2018 | -$12.09M | -22.76% |
| Q2 2018 | -$9.85M | +15.18% |
| Q1 2018 | -$11.61M | -288.52% |
| Q4 2017 | -$2.99M | +46.51% |
| Q3 2017 | -$5.59M | +5.91% |
| Q2 2017 | -$5.94M | +49.13% |
| Q1 2017 | -$11.67M | -3.47% |
| Q4 2016 | -$11.28M | -22.09% |
| Q3 2016 | -$9.24M | -12.35% |
| Q2 2016 | -$8.22M | - |
Free cash flow (FCF) is the cash left after a company covers its operating expenses and capital expenditures. It is the money available to repay debt, buy back shares, pay dividends, or reinvest — making it one of the clearest measures of financial strength.